An Open-label, Phase 1 Drug Drug Interaction study between Tacrolimus and SCY-078 in Healthy male volunteers

Trial Profile

An Open-label, Phase 1 Drug Drug Interaction study between Tacrolimus and SCY-078 in Healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs SCY 078 (Primary) ; Tacrolimus
  • Indications Aspergillosis; Candidiasis; Vulvovaginal candidiasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 Sep 2017 Results presented at the 18th Congress of the European Society for Organ Transplantation
    • 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
    • 12 Apr 2017 According to an SCYNEXIS media release, data from this study will be presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top